Choose a country to view content specific to your location
Choose a country to view content specific to your location
Cancer antigen 50 (CA50) is a glycolipid that is similar to the tumor marker CA19-9; however, CA50 antibodies recognize both the fucosyl form of sialylated Lewis(a) carbohydrate moiety and sialylated Lewis(a) moiety. CA50 is not organ-specific and elevated levels are seen in various conditions such as colitis, pancreatitis, pneumonia, and cancers, especially gastrointestinal cancers (e.g., pancreatic, stomach, hepatic, and colorectal cancers). It can be used as a marker for detecting gastrointestinal cancers, specifically pancreatic and colon cancer. Diagnostic assays for CA50 are based on the antibody sandwich principle using ELISA or CLIA.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
